Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Interventions for Cocaine Cessation
NCT02896712Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Nov 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of modafinil in cocaine use disorder (CUD) (6 arms), sponsored by UTHealth Houston. Primary endpoint: Cocaine Use as Assessed by Proportion of Visits With Cocaine-negative Urine Drug Screen at 4 weeks. Started Nov 2016; status: completed.
02
Drugs
modafinil
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02896712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02896712.